Navigation Links
George Rosenkranz to Receive 2013 Biotechnology Heritage Award
Date:4/21/2013

CHICAGO and PHILADELPHIA, April 21, 2013 /PRNewswire-USNewswire/ -- The Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) have selected George Rosenkranz as the winner of the 2013 Biotechnology Heritage Award. The award will be presented during a keynote lunch on Tuesday, April 23, at BIO's annual international convention, which begins tomorrow in Chicago.

" George Rosenkranz has pioneered with brilliance in steroid chemistry; innovated with legendary success in the pharmaceutical industry; and recruited, mentored, and guided individuals of great talent to stellar careers. He unites in his person European charm, Hispanic courtesy, and American entrepreneurial spirit," says James C. Greenwood , President and CEO of BIO. "George led the development of the oral contraceptive pill, served as chairman of the corporation that brought it to the global market, and thereby permanently changed world culture."

About George Rosenkranz

George Rosenkranz joined Syntex Corporation in 1945 and retired as CEO and board chairman in 1981. During his years with Syntex, Rosenkranz created and guided an academic research group of star-studded brilliance, which included Alex Zaffaroni and Carl Djerassi , first as his junior collaborators, then as his lifelong friends. Revolutionary advances in the intellectual understanding of and production techniques for steroid drugs were developed under Rosenkranz's direction, using native Mexican plant sources as raw materials. Syntex became the leading supplier of the oral contraceptive pill and other corticoids.

Rosenkranz's accomplishments have e
'/>"/>

SOURCE Chemical Heritage Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CanCHEW Bio-Technologies, a Medical Marijuana Inc. Product, Dr. George Anastassov Appeared on Small Cap Voice Internet Radio Program To Discuss The CanCHEW Advantage
2. STATEMENT OF CHAIRMAN AND CEO GEORGE BARRETT FORTUNE 21 CARDINAL HEALTH REGARDING FISCAL CLIFF
3. Fuisz llc Announces Induction of Richard C. Fuisz, M.D., into Georgetown Universitys 1789 Society.
4. One-Time, One Dose Radiation Treatment Offered For Breast Cancer Patients At MedStar Georgetown University Hospital And MedStar Washington Hospital Center
5. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
6. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
7. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
8. Retired Pro Hockey Player 1st to Receive Total Artificial Heart in Upstate New York
9. Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA
10. Nephros Receives 510(k) Clearance for Hemodiafiltration System
11. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 5, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... randomized, double-blinded, placebo-controlled Phase 2 clinical trial of ... in combination with nab-paclitaxel and gemcitabine, versus nab-paclitaxel ... pancreatic cancer who have high serum levels of ... fourth leading cause of cancer death in ...
(Date:5/5/2015)... May 5, 2015   Cynosure, Inc. (Nasdaq: ... devices for aesthetic procedures and precision surgical applications worldwide, ... March 31, 2015. First-Quarter Highlights: , ... , Non-GAAP earnings of $0.15 per share; GAAP earnings ... at March 31, 2015 "Cynosure delivered 21 ...
(Date:5/5/2015)... 5, 2015  Astellas announced that two abstracts detailing ... detailing clinical data from a study of mirabegron as ... a late breaking plenary session at the 2015 annual ... 17 in New Orleans, Louisiana . ... studies designed to evaluate enzalutamide compared to bicalutamide in ...
Breaking Medicine Technology:Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 2Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 3Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 4Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 2Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 3Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 4Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 5Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 6Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 7Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 8Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 9Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 10Cynosure Announces First-Quarter 2015 Results; Posts Record First-Quarter Revenue of $74.9 Million, Up 21 Percent from Prior Year 11Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 2Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 3Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 4Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 5Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 6Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 7Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 8Astellas Announces New Data To Be Presented During Late Breaking Plenary Session At AUA Annual Meeting 9
(Date:5/5/2015)... May 05, 2015 Buckeye Health Plan ... new CEO and plan president of Buckeye Health Plan. ... the position immediately. , Hill has more than 28 ... the Pacific Northwest, from managed care to large health ... and CEO of HealthPlus of Michigan, a health plan ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Igantia ... San Francisco, leads an international initiative to examine key ... extend the human lifespan. Scientists at Igantia believe ... women, from the initiation of her menstrual cycle to ... mechanism for aging and, ultimately, extend the lifespan. ...
(Date:5/5/2015)... 2015 HealthSlide, Inc ., ... solutions for hospitals nationwide, has announced the launch ... CIOs and CTOs can access the calculator on ... both initial and ongoing savings of switching to ... nation’s hospitals pay an average of $300,000 a ...
(Date:5/5/2015)... 05, 2015 After record-breaking sales of ... 2014, Walgreens introduces the Cookies & Cream flavor at ... Extend Nutrition has continually raised the bar for nutritional ... combined with an unprecedented nutritional profile, backed by international ... Extend Nutrition will launch additional new products and expand ...
(Date:5/5/2015)... May 05, 2015 Every year, news articles ... Turns out, the worst dry eye season is spring, also ... in most of the United States. The only season offering ... advocate Sharon Kleyne, host of the Sharon Kleyne Hour™ Power ... her radio show of May 11, 2015. Kleyne is the ...
Breaking Medicine News(10 mins):Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:HealthSlide Launches ROI Cost Calculator 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 2Health News:Nature’s Tears EyeMist tear film supplement soothes dry eye caused by spring pollen season, reports inventor Sharon Kleyne 3
... According to findings of a recent study researchers say bypass ... for many patients // with blocked heart arteries . ... on-pump (work of the heart is shifted to a mechanical ... still beating) surgery. Results of the surgeries were evaluated one ...
... in addition to medication show an improved clinical recovery ... to a new study. ,Researchers examined 126 patients ... in the middle cerebral artery. All the patients were ... of symptom onset. 63 patients were randomly assigned to ...
... cardiovascular disease risk factors, which include high blood pressure, impaired ... the condition is made if you have three out of ... risk for cardiovascular disease. According to a new study, starting ... add extra risk. ,Based on findings of the study ...
... and one of the most frequent causes of indigestion. Typical ... cases. Smoking and a high salt intake significantly increase the ... study. ,Results of the study showed that people ... 70-percent more likely to have acid reflux than non-smokers. Those ...
... more over several years puts one at greater risk for heart ... weight . ,Researchers studied nearly 2,500 adults between ages ... or more during the study, and 20 percent of these people ... and diabetes. But only 4 percent of those who didn't gain ...
... new study shows that not being in optimum cardiovascular health ... say researchers .// ,Researchers say they have found ... cognitive impairment in the elderly. The conditions of metabolic syndrome ... blood glucose levels, high blood pressure, and low levels of ...
Cached Medicine News:
Legionella IgG/M ELISA....
Measles IgM ELISA....
... The Wampole EBV ELISA test ... of assays for the determination ... tests for Viral Capsid Antigen ... Nuclear Antigen (EBNA). Most Wampole ...
Toxo IgG ELISA. All Wampole ELISA kits include the following: 12 x 8 well strips with breakaway wells, sample diluent, controls and calibrators, conjugate, TMB substrate, wash buffer, stop solution,...
Medicine Products: